Evaluate Efficacy and Safety of ChloraSolv When Treating Pressure Ulcers in Need of Debridement
An Open, Single-arm, Multicentre and Interventional Investigation to Evaluate the Debriding Effect of ChloraSolv® on Pressure Ulcers in Need of Debridement
Sponsor: RLS Global
Terminated
RLS Global in bankruptcy
Other terminated trials from RLS Global
More terminations from RLS Global
Other Pressure Ulcer trials with similar outcome
Listed as NCT05547191, this NA trial focuses on Pressure Ulcer and remains terminated or withdrawn. Sponsored by RLS Global, it has been updated 6 times since 2023, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Status Flow
Change History
6 versions recorded-
Sep 2024 — Present [monthly]
Terminated NA
-
Jul 2024 — Sep 2024 [monthly]
Terminated NA
-
Jan 2024 — Jul 2024 [monthly]
Terminated NA
Status: Recruiting → Terminated
-
Nov 2023 — Jan 2024 [monthly]
Recruiting NA
-
Jan 2023 — Nov 2023 [monthly]
Recruiting NA
Status: Not Yet Recruiting → Recruiting
▶ Show 1 earlier version
-
Sep 2022 — Jan 2023 [monthly]
Not Yet Recruiting NA
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- RLS Global
For direct contact, visit the study record on ClinicalTrials.gov .